CompletedNCT01863290
Linking Former Inmates to Primary Care
Studying Idiopathic pulmonary arterial hypertension
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Yale University
- Principal Investigator
- Emily A Wang, MD, MASYale University
- Intervention
- Primary care redesign(other)
- Enrollment
- 816 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2013 – 2016
Study locations (11)
- University of Alabama, Birmingham, Alabama, United States
- Contra Costa Health Services (East and West Contra Costa), Martinez, California, United States
- Southeast Health Center, San Francisco, California, United States
- Santa Clara Health Center, San Jose, California, United States
- Yale Primary Care Center, New Haven, Connecticut, United States
- East Baltimore Medical Center, Baltimore, Maryland, United States
- Boston Healthcare for the Homeless Program, Boston, Massachusetts, United States
- Morningside Clinic, New York, New York, United States
- Montefiore Transition Clinic, New York, New York, United States
- Medicine in Psychiatry Service clinic of the University of Rochester Medical Center, Rochester, New York, United States
- Corporacion SANOS, Caguas, Puerto Rico
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01863290 on ClinicalTrials.govOther trials for Idiopathic pulmonary arterial hypertension
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGNANCT06829589Retrieval of Economic Incentives and Information on Quality-of-care Indicators in Primary CareFundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
- RECRUITINGNANCT06605794FreeFlow Percutaneous Atrial Septal Shunt for IPAHShanghai Zhongshan Hospital
- ACTIVE NOT RECRUITINGNCT05723185Primary Care-Hospital Embedding: a Prospective, Multicentric, Observational StudyRovere Querini Patrizia
- RECRUITINGNANCT05584722Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible IndividualsVanderbilt University Medical Center
- ACTIVE NOT RECRUITINGPHASE2NCT05679570Satralizumab in the Treatment of Pulmonary Arterial Hypertension (SATISFY-JP Trial)International University of Health and Welfare
- RECRUITINGNCT04756076Study Roles of Heavy Metals and Essential Metal Dyshomeostasis in Pulmonary Arterial Hypertension PatientsJiapeng Huang
See all trials for Idiopathic pulmonary arterial hypertension →